Navigation Links
Keck Futures Initiative awards $1M for 15 research projects
Date:5/8/2008

WASHINGTON -- The National Academies Keck FUTURES INITIATIVE announced today the recipients of its 2007 FUTURES grants, each awarded to support interdisciplinary research on aging and healthspan -- the period of life that is free from serious or chronic illness. The 15 projects chosen represent a wide range of approaches to such research, which was the subject of the fifth annual FUTURES conference, "The Future of Human Healthspan: Demography, Evolution, Medicine, and Bioengineering," held last November in Irvine, Calif. A summary of the conference, which explores challenges in this field and possible solutions, is available online at www.keckfutures.org.

John W. Rowe, M.D., professor of health policy and management, Columbia University, New York City, and the conference chair, said, "We received many bold and innovative proposals and believe we have selected the most promising research projects to pursue."

These competitive seed grants aim to fill a critical gap for research on new ideas. Major federal funding programs do not typically provide support in areas that are considered risky or unusual. The FUTURES grants allow researchers to start recruiting students and postdoctoral fellows, purchasing equipment, and acquiring preliminary data all of which can position the researchers to compete for larger awards from other public and private sources.

Established through a $40 million grant from the W.M. Keck Foundation in 2003, the National Academies Keck FUTURES INITIATIVE is a 15-year effort to enhance communication among researchers, funding agencies, universities, and the general public with the objective of stimulating interdisciplinary research at the most exciting frontiers. The National Academies and the W.M. Keck Foundation believe considerable scientific progress and social benefit will be achieved by providing a counterbalance to the tendency to isolate research within academic fields. The FUTURES INITIATIVE is d
'/>"/>

Contact: Maureen O'Leary
news@nas.edu
202-334-2138
The National Academies
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. FutureScripts Promotes Paul Urick to Senior Vice President to Lead the Pharmacy Benefit Management Operation
2. Medical Futures signs North American licensing rights to New Biologic agent for Ulcerative Colitis
3. U.S. Initiative Seeks to Boost Hispanic Stroke Awareness
4. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
5. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
6. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
7. Over 500,000 Health Care Providers Now Cutting Costs, Saving Time Through CAQH Administrative Simplification Initiative
8. Shipcom Partners With DOKUMENTA for METROs Future Store Initiative
9. Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency
10. U.S. Health Initiative Targets Aging Hispanics
11. Muslim Groups Kick Off Ramadan With Anti-Smoking Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... Nov. 21 Today, prescrip...ention in treating 88 percent of patients sufferin... treated for a chronic condition account for 96 pe...cent of all medical costs. A proprietary new phar...lth Solutions, Inc. (NYSE: MHS ) significantly r...
(Date:11/21/2008)...and deadly diseaseits cause remains a mysteryswept...ing with citizens, soldiers and refugees of the wa...s filled with corpses, social order broke down. Ov...e and Athens lost a third of its population. It lo...ginning of the end of the Golden Age of Greece. ,...
(Date:11/21/2008)... Symmetry Medical Inc. (...roducts to the global orthopedic device industry a...an S. Moore, President and Chief Executive Officer...f Financial Officer, are scheduled to present at t...e at The New York Palace Hotel on Wednesday, Decem...
(Date:11/21/2008)..., N.Y. (Nov. 21, 2008) How can moss help us to t...mune system tell us about evolution? Can genetic ...s to conserve rare species? What can quail teach ... diseases? Will studies of choanoflagellates unra...d other questions in biology, scientists are incre...
Breaking Medicine News(10 mins):Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:A new world of research possibilities with 'Emerging Model Organisms' 2
... University of New South Wales have found that dai...he risk// of developing dementia. Dementia is a p...ss of memory and daily activities leading to loss ... presence of irregular knots in brain cells, thoug...
...ive can worsen the clinical condition of cardiac p...ty can reverse the above situation and improve the...at physical activity can complicate a cardiac cond... and excessive strain on the heart. However, a gui...
...itage Insurance Co., the contractor that administe...re has accepted to cover its test. After this the...rose from $2.46 to $12.41 on Nasdaq. The company p...er test. The National Heritage Insurance Co. is t...
...ces the radiation time from six weeks to five days...ss convenient. Doctors// can point the radiation...e study compares the usefulness of the new therapy...t. They are also in the process of analyzing the s...
Other Medicine News:Health News:More Exercise Recommended For Fitness Of Cardiac Patients 2
(Date:11/20/2008)... BOSTON, Nov. 20 PAREXE...eading global biopharmaceutical services provider,...ima, Peru to provide regulatory consulting and cli...the Peru office, PAREXEL now has locations through...tin America, which also include Argentina, Brazil,...
(Date:11/19/2008)... , , Study did not achieve statistical si...wswire-FirstCall/ -- Pharmos Corporation (Nasdaq: ... clinical trial of its topical NanoEmulsion (NE) d...nac Diethanolamine. , , The multi-center, r...y evaluated the safety and efficacy of the Company...
(Date:11/19/2008)... -Triggers $5 Million Payment from Roche- , ,... -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY )...nt goal for its Phase 2 trial of R3487/MEM 3454, i...nitive impairment associated with schizophrenia (C...the Phase 2 trial, triggering a $5.0 million payme...
(Date:11/18/2008)... LANSDOWNE, Va., Nov. 18 /PRNewswire-USNewswire/ ...sts gathered at a November national forum to consi...ca,s public health and national economy from outbr...er announced today. , , Among those innovat...on every American kitchen table that detects highl...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Vendormate Again Selected as Top 40 Georgia Innovative Technology Company 13787 1Vendormate Again Selected as Top 40 Georgia Innovative Technology Company 13787 2New TB test means quicker and easier diagnosis for patients 13783 1New TB test means quicker and easier diagnosis for patients 13783 2New TB test means quicker and easier diagnosis for patients 13783 3Curing addiction with cannabis medicines 13779 1Curing addiction with cannabis medicines 13779 2Wandering albatrosses follow their nose 2438 1Wandering albatrosses follow their nose 2438 2
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients.
The Omni-Flex System provides the capability to change frame arms in the middle of surgery while retaining exposure with tension on the incision. The system is also strong enough to be stable for lar
These retractors, made of rugged Noryl® resin, are pre-sterilized and packaged singly in double peel-pouches for easy delivery to the sterile surgical field.
Pipetman Concept is a revolutionary motorized electronic pipette. Conceived with simplicity and flexibility in mind, Pipetman Concept features exclusive multifunction characteristics and a direct pip
Medicine Products: